SXTPW 60 DEGREES PHARMACEUTICALS, INC.: institutional ownership and insider trading
6 funds reported holding $20.5K of 60 DEGREES PHARMACEUTICALS, INC. in their latest 13F filings; in Q2 2026 funds net sold $2.49K, with 0 new positions and 3 funds selling out; over the last 12 months insiders bought $30.1K and sold $0 on the open market.
Largest institutional holders of SXTPW
- CLEAR STREET LLC — $8.23K
- Walleye Capital LLC — $6.06K
- Clear Street Group Inc. — $4.41K
- TORNO CAPITAL, LLC — $1.43K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $329
- UBS Group AG (UBS) — $20
Recent SXTPW insider trades
- Jun 12, 2026: Dow Geoffrey S bought 7,350 shares ($10.1K)
- Dec 15, 2025: Dow Geoffrey S bought 9,670 shares ($7.74K)
- Dec 11, 2025: Dow Geoffrey S bought 12,963 shares ($12.2K)
- Jun 3, 2025: Xu Cheryl bought 5,000 shares ($14.4K)
5%+ owners
- Knight Therapeutics Inc.: 19.9% (Schedule 13G, filed Jul 29, 2026)
- Mitchell P. Kopin: 9.1% (Schedule 13G/A, filed May 13, 2026)
- CVI Investments, Inc.: 7.0% (Schedule 13G/A, filed May 15, 2026)
- Lind Global Fund III LP: 5.5% (Schedule 13G, filed Aug 5, 2026)